scholarly journals Oral S-1 with 24-h Infusion of Irinotecan plus Bevacizumab versus FOLFIRI plus Bevacizumab as First-Line Chemotherapy for Metastatic Colorectal Cancer: An Open-Label Randomized Phase II Trial

Oncology ◽  
2020 ◽  
Vol 98 (9) ◽  
pp. 637-642
Author(s):  
Sotaro Sadahiro ◽  
Toshiyuki Suzuki ◽  
Kazutake Okada ◽  
Gota Saito ◽  
Hiroshi Miyakita ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
First Line ◽  
Open Label ◽  
Randomized Phase Ii ◽  
Line Chemotherapy

A Randomized Phase II Trial of Pemetrexed plus Irinotecan (ALIRI) versus Leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in First-Line Treatment of Locally Advanced or Metastatic Colorectal Cancer

Oncology ◽  
2007 ◽  
Vol 73 (1-2) ◽  
pp. 9-20 ◽  
Author(s):  
Craig Underhill ◽  
David Goldstein ◽  
Vera A. Gorbounova ◽  
Mikhail Y. Biakhov ◽  
Igor S. Bazin ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Locally Advanced ◽  
Line Treatment ◽  
First Line ◽  
Randomized Phase Ii ◽  
First Line Treatment

scholarly journals Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First‐Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG‐1201 Study)

2018 ◽  
Vol 23 (8) ◽  
pp. 919-927 ◽  
Author(s):  
Goro Nakayama ◽  
Ayako Mitsuma ◽  
Yuki Sunagawa ◽  
Kiyoshi Ishigure ◽  
Hiroyuki Yokoyama ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Japanese Patients ◽  
Line Treatment ◽  
First Line ◽  
Randomized Phase Ii ◽  
First Line Treatment

scholarly journals A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

2005 ◽  
Vol 16 (2) ◽  
pp. 282-288 ◽  
Author(s):  
M.M. Borner ◽  
J. Bernhard ◽  
D. Dietrich ◽  
R. Popescu ◽  
M. Wernli ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Line Treatment ◽  
First Line ◽  
Randomized Phase Ii ◽  
First Line Treatment

A prospective, open-label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first-line chemotherapy in patients with androgen-independent prostate cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 4678-4678 ◽  
Author(s):  
S. Tomek ◽  
K. Elandt ◽  
P. Horak ◽  
W. Albrecht ◽  
M. Eisenmenger ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
First Line ◽  
Open Label ◽  
Weekly Docetaxel ◽  
Randomized Phase Ii ◽  
Line Chemotherapy ◽  
Androgen Independent

Metro-FOLFIRI as first line chemotherapy in metastatic colorectal cancer (MCRC). Preliminary report of a phase II trial

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3722-3722
Author(s):  
M. Nardi ◽  
D. Azzarello ◽  
A. Avallone ◽  
M. Raffaele ◽  
R. Giannicola ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Preliminary Report ◽  
Phase Ii Trial ◽  
First Line ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document